Kewaunee Scientific Corporation

NasdaqGM:KEQU Voorraadrapport

Marktkapitalisatie: US$95.6m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Kewaunee Scientific Beheer

Beheer criteriumcontroles 2/4

De CEO Kewaunee Scientific's is Thomas Hull, benoemd in Mar2019, heeft een ambtstermijn van 5.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.12M, bestaande uit 20.3% salaris en 79.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.62% van de aandelen van het bedrijf, ter waarde $ 1.55M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.6 jaar en 12.4 jaar.

Belangrijke informatie

Thomas Hull

Algemeen directeur

US$2.1m

Totale compensatie

Percentage CEO-salaris20.3%
Dienstverband CEO5.6yrs
Eigendom CEO1.6%
Management gemiddelde ambtstermijn5.6yrs
Gemiddelde ambtstermijn bestuur12.4yrs

Recente managementupdates

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17
Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10
With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23
Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11
Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19
Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

Analyse CEO-vergoeding

Hoe is Thomas Hull's beloning veranderd ten opzichte van Kewaunee Scientific's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2024n/an/a

US$18m

Apr 30 2024US$2mUS$431k

US$19m

Jan 31 2024n/an/a

US$9m

Oct 31 2023n/an/a

US$7m

Jul 31 2023n/an/a

US$4m

Apr 30 2023US$966kUS$384k

US$738k

Jan 31 2023n/an/a

-US$629k

Oct 31 2022n/an/a

-US$3m

Jul 31 2022n/an/a

-US$6m

Apr 30 2022US$870kUS$371k

-US$6m

Jan 31 2022n/an/a

-US$9m

Oct 31 2021n/an/a

-US$7m

Jul 31 2021n/an/a

-US$4m

Apr 30 2021US$707kUS$350k

-US$4m

Jan 31 2021n/an/a

-US$2m

Oct 31 2020n/an/a

-US$4m

Jul 31 2020n/an/a

-US$6m

Apr 30 2020US$674kUS$350k

-US$5m

Jan 31 2020n/an/a

-US$5m

Oct 31 2019n/an/a

-US$3m

Jul 31 2019n/an/a

US$511k

Apr 30 2019US$404kUS$280k

US$2m

Jan 31 2019n/an/a

US$4m

Oct 31 2018n/an/a

US$5m

Jul 31 2018n/an/a

US$6m

Apr 30 2018US$517kUS$262k

US$5m

Compensatie versus markt: De totale vergoeding ($USD 2.12M ) Thomas } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 667.78K ).

Compensatie versus inkomsten: De vergoeding van Thomas is het afgelopen jaar met meer dan 20% gestegen.

CEO

Thomas Hull (48 yo)

5.6yrs

Tenure

US$2,120,403

Compensatie

Mr. Thomas D. Hull, III, has been President and Chief Executive Officer at Kewaunee Scientific Corporation since March 11, 2019 and served as its Chief Financial Officer since November 1, 2015 until April...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Thomas Hull
President5.6yrsUS$2.12m1.62%
$ 1.5m
Donald Gardner
VP of Finance5.5yrsUS$952.98k0.86%
$ 821.1k
Douglas Batdorff
Vice President of Manufacturing Operations4.3yrsUS$551.67k0.29%
$ 282.0k
Ryan Noble
Vice President of Sales & Marketing - Americas6.3yrsUS$333.87k0.46%
$ 443.5k
Elizabeth Phillips
Vice President of Human Resources15.3yrsgeen gegevens0.54%
$ 514.0k
Bhoopathy Sathyamurthy
Managing Director of International Operationsno datageen gegevensgeen gegevens

5.6yrs

Gemiddelde duur

47.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van KEQU is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.6 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Thomas Hull
President5.6yrsUS$2.12m1.62%
$ 1.5m
Keith Gehl
Independent Director9.5yrsUS$115.00k0.58%
$ 552.5k
David Rhind
Independent Chairman16.5yrsUS$120.00k4.63%
$ 4.4m
Margaret Pyle
Independent Director29.7yrsUS$110.00k1.59%
$ 1.5m
Donald Shaw
Independent Director11.3yrsUS$110.00k0.87%
$ 832.2k
John Russell
Independent Director13.4yrsUS$110.00k1.13%
$ 1.1m

12.4yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van KEQU zijn ervaren en ervaren (gemiddelde ambtstermijn van 12.4 jaar).